title: Clinical experience using appetite suppressants and SSRIs.
abstract: The use of sympathomimetic appetite suppressants and serotonin-selective reuptake inhibitors (SSRIs) has been questioned due to anecdotal reports of serotonin syndrome. This survey of bariatric physicians using these medications in clinical practice did not find any cases of serotonin syndrome among 1174 patients. The monitored use of the combination of these medicines by trained practitioners is justifiable.
authors.affiliation: Duke University Medical Center, Durham, NC 27704, USA.
authors.forename: W Alan
authors.initials: WA
authors.lastname: Rader
authors.forename: G Michael
authors.initials: GM
authors.lastname: Steelman
authors.forename: Eric C
authors.initials: EC
authors.lastname: Westman
mesh_terms: D001067:Appetite Depressants / Q000008:administration & dosage* / Q000627:therapeutic use; D052938:Bariatric Medicine / Q000706:statistics & numerical data*; D004359:Drug Therapy, Combination; D006801:Humans; D009765:Obesity / Q000188:drug therapy; D010645:Phentermine / Q000008:administration & dosage* / Q000627:therapeutic use; D010818:Practice Patterns, Physicians'; D020230:Serotonin Syndrome / Q000139:chemically induced; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D011795:Surveys and Questionnaires
chemical_list: D001067:Appetite Depressants; D010645:Phentermine; D017367:Selective Serotonin Reuptake Inhibitors